Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus: Clinical article

Journal of Neurosurgery

Volumn 115, Issue 1, 2011, Pages 145-150

  Tarnaris, Andrew ^a   Toma, Ahmed K ^a   Chapman, Miles D ^b   Keir, Geoff ^b   Kitchen, Neil D ^a   Watkins, Laurence D ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Amyloid ; Biomarkers; Hydrocephalus; Normal pressure hydrocephalus; Outcome; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

AGED; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DISCRIMINANT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROCEPHALUS; INTRACRANIAL PRESSURE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MALE; PEPTIDE FRAGMENTS; PROGNOSIS; TAU PROTEINS; TREATMENT OUTCOME; VENTRICULOPERITONEAL SHUNT;

EID: 79960007080     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.2.JNS101316     Document Type: Article

References (23)

1. Benzel EC, Pelletier AL, Levy PG: Communicating hydrocephalus in adults: prediction of outcome after ventricular shunting procedures. Neurosurgery 26:655-660, 1990 (Pubitemid 20120715)
2. Black PM: Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients. J Neurosurg 52:371-377, 1980
3. Black PM, Ojemann RG, Tzouras A: CSF shunts for dementia, incontinence, and gait disturbance. Clin Neurosurg 32:632-651, 1985
4. Iseki C, Kawanami T, Nagasawa H, Wada M, Koyama S, Kikuchi K, et al: Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: a prospective study in a Japanese population. J Neurol Sci 277:54-57, 2008
5. Jones HC, Klinge PM: Hydrocephalus 2008, 17-20th September, Hannover Germany: a conference report. Cerebrospinal Fluid Res 5:19, 2008
6. Klinge P, Marmarou A, Bergsneider M, Relkin N, Black PM: Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients. Neurosurgery 57:S40-52, 2005
7. Kondziella D, Sonnewald U, Tullberg M, Wikkelso C: Brain metabolism in adult chronic hydrocephalus. J Neurochem 106:1515-1524, 2008
8. Lemcke J, Meier U, Müller C, Fritsch M, Eymann R, Kiefer M, et al: Is it possible to minimize overdrainage complications with gravitational units in patients with idiopathic normal pressure hydrocephalus? Protocol of the randomized controlled SVASONA Trial (ISRCTN51046698). Acta Neurochir Suppl 106:113-115, 2010
9. Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM: The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 57 (3 Suppl):S17-28, 2005
10. Ross CA, Poirier MA: Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 6: 891-898, 2005 (Pubitemid 41568738)
11. Raftopoulos C, Deleval J, Chaskis C, Leonard A, Cantraine F, Desmyttere F, et al: Cognitive recovery in idiopathic normal pressure hydrocephalus: a prospective study. Neurosurgery 35:397-405, 1994 (Pubitemid 24275761)
12. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM: Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57 (3 Suppl):S4-S16, 2005
13. Scollato A, Terreni A, Caldini A, Salvadori B, Gallina P, Francese S, et al: CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment. Neurol Sci 31:283-291, 2010
14. Silverberg GD: Normal pressure hydrocephalus (NPH): ischaemia, CSF stagnation or both. Brain 127:947-948, 2004
15. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D: Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2:506-511, 2003 (Pubitemid 36876108)
16. Talab R, Valis M, Rehak S, Krejsek J: Abnormalities of tauprotein and beta-amyloid in brain ventricle cerebrospinal fluid. Neuro Endocrinol Lett 30:647-651, 2009
17. Tamaoka A, Kondo T, Odaka A, Sahara N, Sawamura N, Ozawa K, et al: Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease. Biochem Biophys Res Commun 205:834-842, 1994 (Pubitemid 24381701)
18. Tarkowski E, Tullberg M, Fredman P, Wikkelsö C: Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. Neurobiol Aging 24:707-714, 2003 (Pubitemid 37288869)
19. Tarnaris A, Toma AK, Chapman MD, Petzold A, Kitchen ND, Keir G, et al: The longitudinal profile of CSF markers during external lumbar drainage. J Neurol Neurosurg Psychiatry 80:1130-1133, 2009
20. Tarnaris A, Toma AK, Kitchen ND, Watkins LD: Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus. Biomarkers Med 3:787-805, 2009
21. Tarnaris A, Watkins LD, Kitchen ND: Biomarkers in chronic adult hydrocephalus. Cerebrospinal Fluid Res 3:11, 2006
22. Tullberg M, Blennow K, Månsson JE, Fredman P, Tisell M, Wikkelsö C: Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Cerebrospinal Fluid Res 5:9, 2008
23. Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelsö C: CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 50:1122-1127, 1998 (Pubitemid 28212848)